Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Brigatinib combined with anti-EGFR antibody overcomes osi... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Brigatinib combined with anti-EGFR antibody overcomes osimertinib resistance in EGFR-mutated non-small-cell lung cancer
0
Authors
Ken Uchibori
7 more
Ken Uchibori
•
Naohiko Inase
5 more
•
Ryohei Katayama
Published
March 13, 2017
Paper
Conversation
0
Reviews
0
Bounties
0
Loading PDF viewer…
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Nature Communications
Topics
Chemistry
Biochemistry
Medicine
Cancer Oncology
Internal Medicine
Show all topics
DOI
10.1038/ncomms14768
License
CC-BY
Other Formats
PDF
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Nature Communications
Topics
Chemistry
Biochemistry
Medicine
Cancer Oncology
Internal Medicine
Show all topics
DOI
10.1038/ncomms14768
License
CC-BY
Other Formats
PDF
